Skip to Content

What type of drug is Copiktra?

Medically reviewed by Last updated on Oct 5, 2020.

Official Answer


Copiktra is a first-in-class, oral inhibitor of PI3K-delta and PI3K-gamma, two enzymes that boost survival of malignant B-cells (an overgrowth of a type of white blood cell in your immune system).

Copiktra (duvelisib), from Verastem Oncology, is used to treat two types of blood cancers in adults:

CLL/SLL and FL are common types of indolent (slow-growing) non-Hodgkin lymphomas (iNHL).

Related Medical Questions

Drug Information

Related Support Groups